Sintx Technologies, Inc. (SINT) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$2.89M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$3.21M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$3.35M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$2.67M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$2.89M | (m) | $452.00K | (m) | $84.00K* | -$2.77M* | (m) | $573.00K | (m) | (m) |
| 2026-03-31 | Reported | (m) | -$3.21M | (m) | $380.00K | (m) | $7.00K | -$2.49M | (m) | $364.00K | (m) | (m) |
| 2025-09-30 | Reported | (m) | -$3.35M | (m) | $208.00K | (m) | $84.00K* | -$2.52M* | (m) | $1.26M | (m) | (m) |
| 2025-06-30 | Reported | (m) | -$2.67M | (m) | $151.00K | (m) | $0.00* | -$2.41M* | (m) | $1.24M | (m) | (m) |
| 2025-03-31 | Reported | (m) | -$2.38M | (m) | $369.00K | (m) | $59.00K | -$1.30M | (m) | $1.12M | (m) | (m) |
| 2024-09-30 | Reported | (m) | -$6.41M | (m) | $799.00K | (m) | $11.00K* | -$2.57M* | (m) | $796.00K | (m) | (m) |
| 2024-06-30 | Reported | (m) | -$2.71M | (m) | $859.00K | (m) | $359.00K* | -$2.21M* | (m) | $1.68M | (m) | (m) |
| 2024-03-31 | Reported | (m) | -$3.20M | (m) | $687.00K | (m) | $174.00K | -$2.73M | (m) | $2.02M | (m) | (m) |
| 2023-09-30 | Reported | (m) | -$3.61M | (m) | $678.00K | (m) | $122.00K* | -$2.92M* | (m) | $2.52M | (m) | (m) |
| 2023-06-30 | Reported | (m) | -$3.46M | (m) | $508.00K | (m) | $98.00K* | -$3.20M* | (m) | $2.15M | (m) | (m) |
| 2023-03-31 | Reported | (m) | -$3.56M | (m) | $539.00K | (m) | $236.00K | -$4.87M | (m) | $2.20M | (m) | (m) |
| 2022-09-30 | Reported | (m) | -$2.79M | (m) | $426.00K | (m) | $511.00K* | -$2.46M* | (m) | $1.52M | (m) | (m) |
| 2022-06-30 | Reported | (m) | -$2.78M | (m) | $240.00K | (m) | $368.00K* | -$2.54M* | (m) | $1.48M | (m) | (m) |
| 2022-03-31 | Reported | (m) | -$2.88M | (m) | $129.00K | (m) | $230.00K | -$3.18M | (m) | $1.65M | (m) | (m) |
| 2021-09-30 | Reported | (m) | -$2.83M | (m) | $239.00K | (m) | $2.58M* | -$2.41M* | (m) | $1.60M | (m) | (m) |
| 2021-06-30 | Reported | (m) | -$2.36M | (m) | $101.00K | (m) | $435.00K* | -$2.35M* | (m) | $1.20M | (m) | (m) |
| 2021-03-31 | Reported | (m) | -$2.84M | (m) | $101.00K | (m) | $191.00K | -$2.99M | (m) | $1.59M | (m) | (m) |
| 2020-09-30 | Reported | (m) | -$2.43M | (m) | $66.00K | (m) | $73.00K* | -$2.12M* | (m) | $1.43M | (m) | (m) |
| 2020-06-30 | Reported | (m) | -$1.98M | (m) | $204.00K | (m) | $56.00K* | -$1.54M* | (m) | $1.07M | (m) | (m) |
| 2020-03-31 | Reported | (m) | -$1.85M | (m) | $207.00K | (m) | $21.00K | -$3.40M | (m) | $994.00K | (m) | (m) |
| 2019-09-30 | Reported | (m) | -$1.70M | (m) | $173.00K | (m) | $126.00K* | -$1.55M* | (m) | $869.00K | (m) | (m) |
| 2019-06-30 | Reported | (m) | -$1.52M | (m) | $167.00K | (m) | (m) | -$1.63M* | (m) | $836.00K | (m) | (m) |
| 2019-03-31 | Reported | (m) | -$1.73M | (m) | $97.00K | (m) | (m) | -$1.70M | (m) | $718.00K | (m) | (m) |
| 2018-09-30 | Reported | (m) | -$7.37M | (m) | (m) | (m) | $41.00K* | -$2.02M* | (m) | $549.00K | (m) | (m) |
| 2018-06-30 | Reported | (m) | -$1.90M | (m) | $2.04M | (m) | $77.00K* | -$3.85M* | (m) | $956.00K | (m) | (m) |
| 2018-03-31 | Reported | (m) | -$2.23M | (m) | (m) | (m) | $34.00K | -$2.08M | (m) | $877.00K | (m) | (m) |
| 2017-09-30 | Reported | (m) | -$1.97M | (m) | (m) | (m) | $409.00K* | -$966.00K* | (m) | $1.02M | (m) | (m) |
| 2017-06-30 | Reported | (m) | -$1.72M | (m) | $3.21M | (m) | $216.00K* | -$1.60M* | (m) | $1.34M | (m) | (m) |
| 2017-03-31 | Reported | (m) | -$1.80M | (m) | (m) | (m) | $292.00K | -$1.83M | (m) | $1.02M | (m) | (m) |
| 2016-09-30 | Reported | (m) | -$3.21M | (m) | (m) | (m) | $77.00K* | -$2.88M* | (m) | $1.58M | (m) | (m) |
| 2016-06-30 | Reported | (m) | -$2.50M | (m) | (m) | (m) | $91.00K* | -$914.00K* | (m) | $1.55M | (m) | (m) |
| 2016-03-31 | Reported | (m) | -$2.48M | (m) | (m) | (m) | $259.00K | -$1.47M | (m) | $1.61M | (m) | (m) |
| 2015-09-30 | Reported | (m) | -$2.81M | (m) | (m) | (m) | $84.00K* | -$1.74M* | (m) | $1.68M | (m) | $0.00 |
| 2015-06-30 | Reported | (m) | -$2.60M | (m) | (m) | (m) | $140.00K* | -$2.35M* | (m) | $1.55M | (m) | $0.00 |
| 2015-03-31 | Reported | (m) | -$4.01M | (m) | (m) | (m) | $277.00K | -$2.97M | (m) | $1.84M | (m) | $0.00 |
| 2014-09-30 | Reported | (m) | -$5.64M | (m) | (m) | (m) | $662.00K* | (m) | (m) | $1.97M | (m) | $0.00 |
| 2014-06-30 | Reported | (m) | -$10.63M | (m) | (m) | (m) | $817.00K* | (m) | (m) | $3.04M | (m) | $0.00 |
| 2014-03-31 | Reported | (m) | -$4.06M | (m) | (m) | (m) | $548.00K | (m) | (m) | $591.00K | (m) | $0.00 |
| 2013-09-30 | Reported | (m) | -$2.02M | (m) | (m) | (m) | $782.00K* | (m) | (m) | $666.00K | (m) | $0.00 |
| 2013-06-30 | Reported | (m) | -$2.67M | (m) | (m) | (m) | $478.00K* | (m) | (m) | $1.15M | (m) | (m) |
| 2013-03-31 | Reported | (m) | -$2.77M | (m) | (m) | (m) | $310.00K | (m) | (m) | $1.06M | (m) | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$10.72M | (m) | $1.02M | (m) | $185.00K | -$8.57M | (m) | $4.59M | (m) | (m) |
| 2024-12-31 | Reported | (m) | -$14.05M | (m) | $2.89M | (m) | $690.00K | -$8.64M | (m) | $5.20M | (m) | (m) |
| 2023-12-31 | Reported | (m) | -$13.36M | (m) | $2.63M | (m) | $530.00K | -$14.12M | (m) | $8.71M | (m) | (m) |
| 2022-12-31 | Reported | (m) | -$11.34M | (m) | $1.56M | (m) | $1.41M | -$10.26M | (m) | $6.45M | (m) | (m) |
| 2021-12-31 | Reported | (m) | -$10.62M | (m) | $606.00K | (m) | $3.74M | -$10.13M | (m) | $5.89M | (m) | (m) |
| 2020-12-31 | Reported | (m) | -$8.50M | (m) | $594.00K | (m) | $360.00K | -$9.11M | (m) | $4.81M | (m) | (m) |
| 2019-12-31 | Reported | (m) | -$6.59M | (m) | $689.00K | (m) | $147.00K | -$6.43M | (m) | $3.39M | (m) | (m) |
| 2018-12-31 | Reported | (m) | -$13.12M | (m) | $95.00K | (m) | $11.00K | -$9.35M | (m) | $2.99M | (m) | (m) |
| 2017-12-31 | Reported | (m) | -$7.49M | (m) | (m) | (m) | $6.00K | -$4.68M | (m) | $3.51M | (m) | (m) |
| 2016-12-31 | Reported | (m) | -$11.54M | (m) | (m) | (m) | $671.00K | -$7.17M | (m) | $6.34M | (m) | (m) |
| 2015-12-31 | Reported | (m) | -$12.04M | (m) | (m) | (m) | $695.00K | -$9.06M | (m) | $6.39M | (m) | (m) |
| 2014-12-31 | Reported | (m) | -$24.17M | (m) | (m) | (m) | $2.17M | -$14.52M | (m) | $6.74M | (m) | (m) |
| 2013-12-31 | Reported | (m) | -$10.34M | (m) | (m) | (m) | $2.33M | (m) | (m) | $3.46M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |